• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[痴呆患者的药物治疗]

[Pharmacotherapy of patients with dementia].

作者信息

Hirsch R D

机构信息

Abteilung für Gerontopsychiatrie und Gerontopsychiatrisches Zentrum, Rheinische Kliniken Bonn.

出版信息

Internist (Berl). 2003 Dec;44(12):1584-96. doi: 10.1007/s00108-003-1083-5.

DOI:10.1007/s00108-003-1083-5
PMID:14689201
Abstract

Dementing illnesses present among the most frequent and most consequential psychiatric disorders in old age. They thus constitute a particular challenge for science politics and society as a whole. Knowledge about multifactorial etiological and pathological factors is still rather limited. By way of stratified diagnostic procedures various dementia disorders can be differentiated rather reliably. Anti-dementia drugs can enhance cognitive performance and temporarily slow down the progress of the most frequently occurring dementias (Alzheimer-dementia, vascular dementia). In the treatment of behavioral symptoms in dementia newly developed psychopharmological agents are of particular relevance. They constitute an important element of a multi-modal therapeutic strategy.

摘要

痴呆症是老年人群中最常见且后果最为严重的精神疾病之一。因此,它们对科学、政策和整个社会构成了特殊挑战。关于多因素病因和病理因素的知识仍然相当有限。通过分层诊断程序,可以较为可靠地区分各种痴呆症。抗痴呆药物可以提高认知能力,并暂时减缓最常见痴呆症(阿尔茨海默病性痴呆、血管性痴呆)的进展。在治疗痴呆症的行为症状方面,新开发的精神药物具有特别重要的意义。它们是多模式治疗策略的重要组成部分。

相似文献

1
[Pharmacotherapy of patients with dementia].[痴呆患者的药物治疗]
Internist (Berl). 2003 Dec;44(12):1584-96. doi: 10.1007/s00108-003-1083-5.
2
[Early diagnosis and therapy of Alzheimer dementia. Careful documentation prevents degeneration].[阿尔茨海默病性痴呆的早期诊断与治疗。仔细记录可预防病情恶化]
MMW Fortschr Med. 2002 Nov 21;144(47):53-4.
3
How do we treat people with dementia in Croatia.我们在克罗地亚如何治疗痴呆症患者。
Psychiatr Danub. 2010 Jun;22(2):363-6.
4
[Alzheimer's disease--treatment with and without drugs].[阿尔茨海默病——药物治疗与非药物治疗]
MMW Fortschr Med. 2012 Apr 19;154(7):85-7, 89-90.
5
[Consensus statement "Dementia 2010" of the Austrian Alzheimer Society].[奥地利阿尔茨海默病协会《2010年痴呆症共识声明》]
Neuropsychiatr. 2010;24(2):67-87.
6
[Cost of illness in Alzheimer's disease].[阿尔茨海默病的疾病成本]
Med Klin (Munich). 2010 May;105(5):327-33. doi: 10.1007/s00063-010-1060-4. Epub 2010 May 26.
7
Counting costs. Patients will suffer from limits on Alzheimer's drugs.计算成本。患者将因阿尔茨海默病药物的限制而受苦。
Nurs Stand. 2005;19(37):24-5. doi: 10.7748/ns.19.37.24.s25.
8
Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias.胆碱酯酶抑制剂在阿尔茨海默病及相关痴呆症治疗中的应用
Clin Geriatr Med. 2004 Feb;20(1):59-68. doi: 10.1016/j.cger.2003.11.002.
9
[Dementia--treatment].[痴呆症——治疗]
Dtsch Med Wochenschr. 2003 Jul 11;128(28-29):1544-6; quiz 147-50. doi: 10.1055/s-2003-40382.
10
[Cost-effectiveness of galantamine in a german context].[加兰他敏在德国背景下的成本效益]
Psychiatr Prax. 2005 Apr;32(3):142-50. doi: 10.1055/s-2004-834709.

引用本文的文献

1
[Persons with dementia caught between medicine, care and politics].[痴呆症患者处于医学、护理与政治之间的困境]
Z Gerontol Geriatr. 2008 Apr;41(2):106-16. doi: 10.1007/s00391-008-0535-x. Epub 2008 Apr 3.

本文引用的文献

1
[Pathomechanisms and hypothesis-guided therapeutic strategies for late-onset Alzheimer's disease].[迟发性阿尔茨海默病的发病机制及基于假说的治疗策略]
Fortschr Neurol Psychiatr. 2003 Jul;71 Suppl 1:S16-26. doi: 10.1055/s-2003-40501.
2
[Socio- and psychotherapy in patients with Alzheimer disease].
Z Gerontol Geriatr. 2001 Apr;34(2):92-100. doi: 10.1007/s003910170072.
3
[Dementia syndrome and Alzheimer disease: an assessment of morbidity and annual incidence in Germany].[痴呆综合征与阿尔茨海默病:德国的发病率及年发病率评估]
Gesundheitswesen. 2000 Apr;62(4):211-8. doi: 10.1055/s-2000-10858.
4
[Effect pf anti-dementia drugs on the daily routine and attitude of dementia patients].[抗痴呆药物对痴呆患者日常生活及态度的影响]
Z Gerontol Geriatr. 1999 Jun;32(3):167-71. doi: 10.1007/s003910050101.
5
[Psychopharmacotherapy of behavioral disorders in patients with dementia].
Z Gerontol Geriatr. 1999 Jun;32(3):153-8. doi: 10.1007/s003910050099.
6
Evaluating dementia screening tests: methodologic standards to rate their performance.评估痴呆筛查测试:评价其性能的方法学标准。
Neurology. 1999 Jan 15;52(2):224-7. doi: 10.1212/wnl.52.2.224.
7
Prevalence and severity of cognitive impairment with and without dementia in an elderly population.老年人群中伴有和不伴有痴呆的认知障碍的患病率及严重程度。
Lancet. 1997 Jun 21;349(9068):1793-6. doi: 10.1016/S0140-6736(97)01007-6.
8
Status of risk factors for dementia associated with stroke.与中风相关的痴呆症危险因素状况。
Stroke. 1997 Feb;28(2):459-63. doi: 10.1161/01.str.28.2.459.
9
The new neuropathology of degenerative frontotemporal dementias.退行性额颞叶痴呆的新神经病理学
Acta Neuropathol. 1996;91(2):127-34. doi: 10.1007/s004010050403.
10
Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Prospective studies collaboration.胆固醇、舒张压与中风:45个前瞻性队列中45万人的13000例中风。前瞻性研究协作组
Lancet. 1995;346(8991-8992):1647-53.